TG Therapeutics' stock rose 15% since my November buy recommendation, driven by Briumvi's strong performance and strategic ...

Among others, the meeting was attended by key stakeholders, including the Secretary Industries and Production, Chairman NADRA, CEO SMEDA and Chief Statistician and Member (Support Service) of Pakistan ...

While HUN faces headwinds from soft demand in certain markets, it gains on actions to grow its downstream specialty and formulation businesses and acquisitions.

Cybin (NYSE American: CYBN) (NEO: CYBN) , a neuropsychiatry platform company, announced its first strategic partnership agreement (“SPA”) with Segal Trials as part of its multinational pivotal Phase 3 ...

New research published in the New England Journal of Medicine has shown a single dose of the influenza vaccine is sufficient ...

ONS-5010 demonstrated to be non-inferior to Lucentis at 12 weeksBLA resubmission on track for calendar Q1 2025Entered into agreements for warrant ...

Rubicon Research plans Rs ₹500 crore IPO for growth, acquisitions, and loan repayment, with strong US market presence.

ONS-5010 demonstrated to be non-inferior to Lucentis at 12 weeksBLA resubmission on track for calendar Q1 2025Entered into agreements for warrant inducement transaction expected to result in up to $20 ...

BASF’s Coatings division announces that BMW Group has selected the premium refinish brands Glasurit and R-M among their ...

The OTC pain medication market is set to achieve significant valuation growth by 2034, up from 2024 levels. The market is ...

JTA International Investment Holding is pleased to announce a strategic investment of 45 million Euros in Sepidan Drilling ...

As for Germany, Robert Kaplan writes in his illuminating book "The Revenge of Geography" it "faces both east and west with no mountain ranges to protect it, providing it with pathologies from ...